TechnipFMC holder reports 6.5% stake via T. Rowe Price
T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting a significant position in TechnipFMC plc common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
T. Rowe Price Associates, Inc. filed an amended Schedule 13G reporting a significant position in TechnipFMC plc common stock. The firm reports beneficial ownership of 25,718,037 shares, representing 6.5% of the outstanding common stock identified by CUSIP G87110105.
T. Rowe Price Associates reports sole voting power over 25,472,131 shares and sole dispositive power over the full 25,718,037 shares, with no shared voting or dispositive power. The firm states that the filing should not be construed as an admission that it is the beneficial owner of these securities and expressly denies such beneficial ownership.
Key Figures
Key Terms
Schedule 13G/A regulatory
beneficial owner regulatory
sole voting power financial
sole dispositive power financial
percent of class financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in TechnipFMC (FTI) does T. Rowe Price Associates report?
What is the sole dispositive power reported by T. Rowe Price Associates for TechnipFMC (FTI)?
Where is T. Rowe Price Associates, Inc. organized and located in this TechnipFMC (FTI) filing?
Does T. Rowe Price Associates admit beneficial ownership of its TechnipFMC (FTI) position?
AI-generated analysis. How Rhea-AI works. Not financial advice.